Sponsor or institution
Clinical trials and research at Janux Therapeutics
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Janux Therapeutics that are recruiting, at sites in 3 countries (most in United States (3), Australia (2), Spain (1)). By phase: Phase 1 (3), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| JANX013 and JANX007 combo in advanced prostate cancer | Phase 1 | Nashville, Tennessee | Recruiting | Sep 10, 2026 |
| JANX014 for metastatic castration-resistant prostate cancer | Phase 1 | La Jolla, California and 5 other locations | Recruiting | Apr 22, 2026 |
| Testing JANX011 for safety and tolerability in healthy adults. | Early Phase 1 | Adelaide, South Australia | Recruiting | Dec 18, 2025 |
| Testing JANX007 for advanced prostate cancer | Phase 1 | Birmingham, Alabama and 37 other locations | Recruiting | Aug 29, 2022 |
All recruiting trials (4)
-
JANX013 and JANX007 combo in advanced prostate cancer
A first-in-human study will test JANX013 together with JANX007 to see if this combination is safe and tolerable in adults with metastatic castration-resistant prostate cancer.
-
JANX014 for metastatic castration-resistant prostate cancer
This trial will test whether JANX014 is safe, how your body handles it, and whether it shows signs of benefit in adults with metastatic castration-resistant prostate cancer who have already had anti-androgen therapy and typically a taxane.
-
Testing JANX011 for safety and tolerability in healthy adults.
This trial tests JANX011 given by injection in healthy adults to see if it is safe, well tolerated, and to measure how the drug behaves and affects the immune system.
-
Testing JANX007 for advanced prostate cancer
This study is testing a new treatment called JANX007 combined with Darolutamide to see if it helps adults with advanced prostate cancer who haven't responded to other therapies.
Quick answers
How many clinical trials run by Janux Therapeutics are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), Australia (2 trials), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.